These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 25302170)

  • 1. Cyclooxygenase-2 and the inflammogenesis of breast cancer.
    Harris RE; Casto BC; Harris ZM
    World J Clin Oncol; 2014 Oct; 5(4):677-92. PubMed ID: 25302170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.
    Harris RE
    Subcell Biochem; 2007; 42():93-126. PubMed ID: 17612047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer.
    Harris RE; Robertson FM; Abou-Issa HM; Farrar WB; Brueggemeier R
    Med Hypotheses; 1999 Apr; 52(4):291-2. PubMed ID: 10465664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice.
    Gonçalves RM; Delgobo M; Agnes JP; das Neves RN; Falchetti M; Casagrande T; Garcia APV; Vieira TC; Somensi N; Bruxel MA; Mendes DAGB; Rafacho A; Báfica A; Gelain DP; Moreira JCF; Cassali GD; Bishop AJR; Zanotto-Filho A
    Cancer Lett; 2021 Apr; 502():44-57. PubMed ID: 33429006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
    Richards JA; Petrel TA; Brueggemeier RW
    J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
    Harris RE
    Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.
    Díaz-Cruz ES; Brueggemeier RW
    Anticancer Agents Med Chem; 2006 May; 6(3):221-32. PubMed ID: 16712450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.
    Subbaramaiah K; Morris PG; Zhou XK; Morrow M; Du B; Giri D; Kopelovich L; Hudis CA; Dannenberg AJ
    Cancer Discov; 2012 Apr; 2(4):356-65. PubMed ID: 22576212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism.
    Subbaramaiah K; Howe LR; Port ER; Brogi E; Fishman J; Liu CH; Hla T; Hudis C; Dannenberg AJ
    Cancer Res; 2006 May; 66(10):5504-11. PubMed ID: 16707480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2: a potential target in breast cancer.
    Wang D; Dubois RN
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):64-73. PubMed ID: 15052544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B; Goss P
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions.
    Bowers LW; Maximo IX; Brenner AJ; Beeram M; Hursting SD; Price RS; Tekmal RR; Jolly CA; deGraffenried LA
    Cancer Res; 2014 Aug; 74(16):4446-57. PubMed ID: 25125682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
    Brueggemeier RW; Díaz-Cruz ES
    Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
    Brueggemeier RW; Díaz-Cruz ES; Li PK; Sugimoto Y; Lin YC; Shapiro CL
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):129-36. PubMed ID: 15964185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.
    Müller-Decker K; Berger I; Ackermann K; Ehemann V; Zoubova S; Aulmann S; Pyerin W; Fürstenberger G
    Am J Pathol; 2005 Feb; 166(2):575-84. PubMed ID: 15681840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.
    Davies G; Martin LA; Sacks N; Dowsett M
    Ann Oncol; 2002 May; 13(5):669-78. PubMed ID: 12075734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.
    Howe LR
    Breast Cancer Res; 2007; 9(4):210. PubMed ID: 17640394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.
    Brueggemeier RW; Quinn AL; Parrett ML; Joarder FS; Harris RE; Robertson FM
    Cancer Lett; 1999 Jun; 140(1-2):27-35. PubMed ID: 10403538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.
    Mandal A; Bhatia D; Bishayee A
    Mol Carcinog; 2014 Dec; 53(12):999-1010. PubMed ID: 23846978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
    Badawi AF; Badr MZ
    Int J Cancer; 2003 Jan; 103(1):84-90. PubMed ID: 12455057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.